Entospletinib (GS-9973)

For research use only.

Catalog No.S7523

14 publications

Entospletinib (GS-9973) Chemical Structure

Molecular Weight(MW): 411.46

Entospletinib (GS-9973) is an orally bioavailable, selective Syk inhibitor with IC50 of 7.7 nM in a cell-free assay and showed 13- to >1000-fold cellular selectivity for Syk over other kinases(including Jak2, ckit, Flt3, Ret, KDR) as assessed by target protein phosphorylation or functional response.

Size Price Stock Quantity  
EUR 144 In stock
EUR 262 In stock
EUR 468 In stock
EUR 940 In stock
Bulk Discount
Bulk Inquiry

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's Entospletinib (GS-9973) has been cited by 14 publications

4 Customer Reviews

  • Dose titration effects of sotrastaurin (Sotr), GS-9973 (GS) on GSK-3 and AKT phosphorylation were evaluated in anti-IgM-stimulated CLL cells. One representative experiment out of 3 performed is shown.

    Blood, 2016, 127(25):3192-201. Entospletinib (GS-9973) purchased from Selleck.

  • (B) SYK(pY352) and PLCγ2(pY759) in CVID patients' CD21low B cells untreated (filled circles), in the presence of Entospletinib (open circle), or after washout of the inhibitor (gray circles) (n = 5).

    J Hematol Oncol, 2018, 11(1):23. Entospletinib (GS-9973) purchased from Selleck.

  • TF-1 cells were stimulated with EPO (10 U/ml) or GM-CSF (10 ng/ml), either in the absence or presence of R406 (1 μM) or GS-9973 (1 μM) for indicated time periods. Total cell lysates were analyzed by immunoblotting using indicated antibodies.

    Biochim Biophys Acta, 2017, 1864(4):687-696. Entospletinib (GS-9973) purchased from Selleck.

  • (A) FcγRIIB+ Ramos cells were pre-treated with Syk inhibitor Entospletinib (GS-9973) then stimulated for 5 min with the indicated anti-IgM antibody, lysed and subjected to co-immuoprecipitation with specific antibody or isotype control. Eluates were separated by SDS-PAGE and western blotting was performed with the indicated antibodies.

    J Immunol, 2016, 197(5):1587-96.. Entospletinib (GS-9973) purchased from Selleck.

Purity & Quality Control

Choose Selective Syk Inhibitors

Biological Activity

Description Entospletinib (GS-9973) is an orally bioavailable, selective Syk inhibitor with IC50 of 7.7 nM in a cell-free assay and showed 13- to >1000-fold cellular selectivity for Syk over other kinases(including Jak2, ckit, Flt3, Ret, KDR) as assessed by target protein phosphorylation or functional response.
Features Orally bioavailable Syk-selective inhibitor that has been tested in Phase II clinical trials for treatment of Haematological Malignancies.
Targets
Syk [1]
(Cell-free assay)
7.7 nM
In vitro

GS-9973 shows good bidirectional permeability across Caco-2 cell monolayers in vitro. In cells, GS-9973 also shows excellent selectivity for Syk, and potently inhibits BCR-mediated activation and proliferation of B-cells as well as immune-complex-stimulated cytokine production in monocytes. [1] The combination of idelalisib and GS-9973 synergistically inhibits CLL cell viability and further disrupts chemokine signaling. [2]
Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
human MV411 cells  MljiVJJwdGmoZYLheIlwdiCjc4PhfS=> NUPERW9qPzJiaB?= MWXJcohq[mm2aX;uJI9nKE[udEOgbY4hcHWvYX6gUXY1OTFiY3XscJMh[XO|ZYPz[YQh[XNiYYPz[ZN{\WRiYYOgdJJwdGmoZYLheIlwdiCjZoTldkA4OiCqcoOgbY5kfWKjdHnvckBjgSC|cHXjeJJweGixdH;t[ZRzgSxiRVO1NF0xNjN{NzFOwG0> NGPOcYYzPDd5OUWxOC=>
C57BL/6 mouse bone marrow cells MoToR5l1d3SxeHnjxsBie3OjeR?= MlzVOEBl[Xm| NGH4ZmhEgXSxdH;4bYNqfHliYXfhbY5{fCCFNUfCUE83KG2xdYPlJIJwdmVibXHydo94KGOnbHzzJIF{e2W|c3XkJIF{KGe{b4f0bEBqdmirYnn0bY9vKHC{ZXnuZ5Vj[XSnZDDmc5IhPCCmYYnzJIZwdGyxd3XkJIJ6KFt|SG2teIh6dWmmaX7lJIFl\Gm2aX;uJI1m[XO3cnXkJIFnfGW{IEWgbJJ{KGK7IHLleIFxdGG2ZTDjc5VvfGmwZzDhcoFtgXOrczygTWM2OD1yLkW4NkDPxE1? M13RbFI2PjN|N{Sx

... Click to View More Cell Line Experimental Data
Assay
Methods Test Index PMID
Western blot
p-ERBB2 / ERBB2 / pEGFR / EGFR ; 

PubMed: 31492560     


MPSC1TR cells were serum starved and treated with SYK inhibitors including R406 (700  nM) and entospletinib (ENTO) (700 nM) overnight, and then induced with 0, 20, or 100 ng/mL EGF. The expression of phospho- and total ERBB2 and EGFR were determined by Western blotting. 

SYK / p-SYK ; 

PubMed: 29537660     


Immunoblots of indicated proteins in LX-2 and TWNT-4 cells treated with different concentrations of GS-9973.

31492560 29537660
In vivo GS-9973 (1 mg/kg p.o.) shows moderate to high bioavailability in rat and dog. In a rat collagen-induced arthritis model, GS-9973 (1-10 mg/kg p.o.) significantly inhibits ankle inflammation. Moreover, GS-9973 also shows disease-modifying activity in multiple histological measurements, including inhibition of pannus formation, cartilage damage, bone resorption, and peritosteal bone formation with ED50 ranging from 1.2 to 3.9 mg/kg . [1]

Protocol

Kinase Assay:

[1]
- Collapse

Kinase Assays:

Full-length baculovirus-expressed Syk kinase activity is measured in a Lance-based assay format in a final volume of 25 μL containing 25 mM Tris–HCl, pH 7.5, 5 mM β-glycerophosphate, 2 mM DTT, 0.1 mM Na3VO4, 10 mM MgCl2, 0.5 μM Promega PTK biotinylated peptide substrate 1, 0.01% casein, 0.01% Triton X-100, 0.25% glycerol, and 40 mM ATP (Km for ATP) incubated at room temperature for 60 min. Reactions are stopped with the addition of 30 mM EDTA containing 30 μL of SA-APC and 4 nM PT-66 antibody and the plates measured on a Perkin-Elmer Envision. IC50 values for test compounds are determined using a four-parameter linear regression algorithm.
Cell Research:

[1]
- Collapse
  • Cell lines: MV-4-11 cells
  • Concentrations: ~10 μM
  • Incubation Time: 72 hours
  • Method:

    Functional impact on cellular Flt3 activity is determined by measuring compound inhibition of MV-4-11 cell proliferation. A total of 104 cells are diluted in RPMI medium containing 10% FBS in 96-well flat-bottomed tissue culture plates and incubated with compound dilutions for 72 h at 37 癈. Alamar blue (10%) is added to the cells, which were incubated for an additional 12-18 h at 37 癈, and inhibition of the relative cell numbers is determined by spectrophotometer readings at 570/600 nm.


    (Only for Reference)
Animal Research:

[1]
- Collapse
  • Animal Models: Rat Collagen-Induced Arthritis (CIA) Model
  • Dosages: ~10 mg/kg bid
  • Administration: p.o.
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 26 mg/mL warmed (63.18 mM)
Water Insoluble
Ethanol Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
4% DMSO+30% PEG 300+5% Tween 80+ddH2O
For best results, use promptly after mixing. 		2.5mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 411.46
Formula

C23H21N7O
CAS No. 1229208-44-9
Storage powder
in solvent
Synonyms N/A
Smiles C1COCCN1C2=CC=C(C=C2)NC3=NC(=CN4C3=NC=C4)C5=CC6=C(C=C5)C=NN6

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    How should we use S7523 to perform intraperitoneal injection in mice?

  • Answer:

    S7523 can be dissolved in 4% DMSO/30% PEG 300/5% Tween 80/ddH2O at up to 2.5mg/ml and use it for intra peritoneal injection in mice. When making this vehicle, please dissolve the product in DMSO first, then add PEG 300 and Tween 80 and dilute with water as a final step.

selleck catalog

Syk Signaling Pathway Map

Related Syk Products

  • PX-478 2HCl New

    PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1α (HIF-1α) inhibitor. PX-478 2HCl induces apoptosis and has anti-tumor activity. Phase 1.

  • Defactinib (VS-6063) New

    Defactinib (VS-6063, PF-04554878) is a selective, and orally active FAK inhibitor. Phase 2.

  • SU6656 New

    SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.

  • R406 (free base)

    R406 (free base) is a potent Syk inhibitor with IC50 of 41 nM in a cell-free assay, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. R406 (free base) triggers apoptosis. Phase 1.

  • R406

    R406 is a potent Syk inhibitor with IC50 of 41 nM in cell-free assays, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. R406 induces apoptosis. Phase 1.

    Features:Lead drug candidate for rheumatoid arthritis.

  • R788 (Fostamatinib) Disodium

    R788 (Fostamatinib) disodium, a prodrug of the active metabolite R406, is a Syk inhibitor with IC50 of 41 nM in a cell-free assay, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 3.

    Features:Clinically used oral formulation of R406.

  • Fostamatinib (R788)

    Fostamatinib (R788), a prodrug of the active metabolite R406, is a Syk inhibitor with IC50 of 41 nM, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 3.

    Features:Converted into its active metabolite R406 in vivo.

  • Piceatannol

    Piceatannol, a natural stilbene, is a selective Syk inhibitor and ~10-fold selectivity versus Lyn.

  • PRT062607 (P505-15) HCl

    PRT062607 (P505-15, BIIB057) HCl is a novel, highly selective Syk inhibitor with IC50 of 1 nM in cell-free assays, >80-fold selective for Syk than Fgr, PAK5, Lyn, FAK, Pyk2, FLT3, MLK1 and Zap70.

  • Ibrutinib (PCI-32765)

    Ibrutinib (PCI-32765) is a potent and highly selective Brutons tyrosine kinase (Btk) inhibitor with IC50 of 0.5 nM in cell-free assays, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc. Ibrutinib is applicable as a Btk ligand in the synthesis of a series of PROTACs including P13I.

Tags: buy Entospletinib|Entospletinib ic50|Entospletinib price|Entospletinib cost|Entospletinib solubility dmso|Entospletinib purchase|Entospletinib manufacturer|Entospletinib research buy|Entospletinib order|Entospletinib mouse|Entospletinib chemical structure|Entospletinib mw|Entospletinib molecular weight|Entospletinib datasheet|Entospletinib supplier|Entospletinib in vitro|Entospletinib cell line|Entospletinib concentration|Entospletinib nmr|Entospletinib in vivo|Entospletinib clinical trial|Entospletinib inhibitor|Entospletinib Angiogenesis inhibitor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID